logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Self-reported antiretroviral therapy in injection drug users.

    Article - En anglais

    Context. - The US Public Health Service and the International AIDS Society-USA recently published recommendations for antiretroviral therapy (ART) for persons infected with human immunodeficiency virus (HIV) ; however, anecdotal evidence suggests that HIV-infected injection drug users (IDUs) may not be receiving optimal care as defined by the recommendations.

    Objective

    - To assess ART use in HIV-infected IDUs.

    Design

    - A cross-sectional survey of self-reported ART use between July 1996 and June 1997 in IDUs.

    Setting

    - A community-based clinic affiliated with Johns Hopkins University, Baltimore, Md.

    Participants

    - A total of 404 HIV-infected IDUs with CD4+cell counts less than 0.50 x 109/L recruited into a longitudinal study in 1988 and 1989.

    Main Outcome Measure

    - Self-reported ART use was assessed : no current therapy, monotherapy, or combination therapy with or without a protease inhibitor.

    Results

    - One half (199/404 [49% ]) of patients reported no recent ART.

    A total of 14% (58/404) had monotherapy, 23% (90/404) were receiving combination therapy without a protease inhibitor, and 14% (57/404) had triple-combination therapy with a protease inhibitor.

    A multivariate analysis of factors associated with ART showed that care continuity and recent HIV-related outpatient visit (odds ratio [OR], 4.30 ; 95% confidence interval [CI], 2.36-7.81 and OR, 2.84 ; 95% CI, 1.66-4.88, respectively), CD4+cell count of less than 0.20x 109 (OR, 2.41 ; 95% CI, 1.51-3. (...)

    Mots-clés Pascal : Toxicomanie, SIDA, Virose, Infection, Chimiothérapie, Retroviridae, Virus, Comportement, Traitement, Efficacité traitement, Homme, Recommandation, Etats Unis, Amérique du Nord, Amérique, Immunopathologie, Immunodéficit

    Mots-clés Pascal anglais : Drug addiction, AIDS, Viral disease, Infection, Chemotherapy, Retroviridae, Virus, Behavior, Treatment, Treatment efficiency, Human, Recommendation, United States, North America, America, Immunopathology, Immune deficiency

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0394484

    Code Inist : 002B06D01. Création : 25/01/1999.